Incyte Corporation - Common Stock — balance (NASDAQ:INCY)

Financials

Activos totales 3.56 B4.93 B5.84 B6.78 B5.44 B6.96 B Total de pasivos 949.65 M1.16 B1.47 B1.59 B2 B1.79 B Capital total 2.61 B3.77 B4.37 B5.19 B3.45 B5.17 B Total de pasivos y patrimonio neto 3.56 B4.93 B5.84 B6.78 B5.44 B6.96 B Deuda total —————— Deuda neta ——————

Incyte Corporation - Common Stock

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

INCY

Financials

Incyte Corporation - Common Stock

Noticias

Why Is Agios Pharmaceuticals (AGIO) Up 8.6% Since Last Earnings Report?

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

Why Is Incyte (INCY) Down 1.8% Since Last Earnings Report?

Here's Why Incyte (INCY) is a Strong Momentum Stock

Here's Why Incyte (INCY) is a Strong Value Stock

Bernstein inicia cobertura de Incyte con dudas sobre su crecimiento

Why Incyte (INCY) is a Top Growth Stock for the Long-Term

H.C. Wainwright mantiene su precio objetivo en 135 dólares para Incyte

Incyte Corporation (INCY) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Incyte Stock: Analyst Estimates & Ratings

Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)

Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised